In order to improve the anti-tumour activity of NK cells in immunotherapy, they produced an EGFR-CAR-NK cell, and finally obtained anti- glioblastomas effects in both in vivo and in vitro experiments in xenograft models. The gene discussed is EGFR; the disease is neoplasm.